13.65
-0.42(-2.99%)
Currency In USD
| Previous Close | 14.07 |
| Open | 14.07 |
| Day High | 14.49 |
| Day Low | 13.63 |
| 52-Week High | 21.73 |
| 52-Week Low | 5.28 |
| Volume | 3.62M |
| Average Volume | 6.93M |
| Market Cap | 2.5B |
| PE | -21 |
| EPS | -0.65 |
| Moving Average 50 Days | 12.37 |
| Moving Average 200 Days | 8.65 |
| Change | -0.42 |
If you invested $1000 in Wave Life Sciences Ltd. (WVE) 10 years ago, it would be worth $891.57 as of January 17, 2026 at a share price of $13.65. Whereas If you bought $1000 worth of Wave Life Sciences Ltd. (WVE) shares 5 years ago, it would be worth $1,528.56 as of January 17, 2026 at a share price of $13.65.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio
GlobeNewswire Inc.
Jan 12, 2026 12:30 PM GMT
Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and comorbidities in 1H 2026, and initiate new trials of WVE-007 as an add-on to incretin and as post-incretin
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 05, 2026 1:30 PM GMT
CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno,
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
GlobeNewswire Inc.
Dec 10, 2025 2:50 AM GMT
CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”),